Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An update on infective endocarditis of dental origin.
Tomás Carmona I, Diz Dios P, Limeres Posse J, González Quintela A, Martínez Vázquez C, Castro Iglesias A. Tomás Carmona I, et al. J Dent. 2002 Jan;30(1):37-40. doi: 10.1016/s0300-5712(01)00056-2. J Dent. 2002. PMID: 11741733
[Cerebral abscesses of oral origin].
Limeres-Posse J, Tomás-Carmona I, Fernández-Feijoo J, Martínez-Vázquez C, Castro-Iglesias A, Diz-Dios P. Limeres-Posse J, et al. Rev Neurol. 2003 Aug 1-15;37(3):201-6. Rev Neurol. 2003. PMID: 12938049 Free article. Spanish.
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.
Rotea-Salvo S, Martínez-Pradeda A, Fernández-Oliveira C, Giménez-Arufe V, Balboa-Barreiro V, Margusino-Framiñán L, Mena-De-Cea Á, Vázquez-Rodríguez P, Castro-Iglesias Á, López-Calvo S, Martín-Herranz I, Míguez-Rey E, Cid-Silva P. Rotea-Salvo S, et al. Among authors: castro iglesias a. Eur J Hosp Pharm. 2023 Jul;30(4):221-226. doi: 10.1136/ejhpharm-2021-002896. Epub 2021 Oct 14. Eur J Hosp Pharm. 2023. PMID: 34649965
Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.
Garcia-Cehic D, Rando A, Rodriguez-Frias F, Gregori J, Costa JG, Carrión JA, Macenlle R, Pamplona J, Castro-Iglesias A, Cañizares A, Tabernero D, Campos C, Buti M, Esteban JI, Quer J. Garcia-Cehic D, et al. Among authors: castro iglesias a. J Viral Hepat. 2021 Sep;28(9):1319-1324. doi: 10.1111/jvh.13497. Epub 2021 Mar 22. J Viral Hepat. 2021. PMID: 33720484
Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain.
Rivero-Juarez A, Frias M, Lopez-Lopez P, Berenguer J, García F, Macias J, Alcaraz B, Castro-Iglesias A, Caballero-Gomez J, Rivero A. Rivero-Juarez A, et al. Among authors: castro iglesias a. Front Microbiol. 2020 Sep 11;11:564486. doi: 10.3389/fmicb.2020.564486. eCollection 2020. Front Microbiol. 2020. PMID: 33716992 Free PMC article.
Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus.
Margusino-Framiñán L, Cid-Silva P, Giménez-Arufe V, Mondelo-García C, Fernández-Oliveira C, Mena-de-Cea Á, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Among authors: castro iglesias a. Eur J Hosp Pharm. 2021 Jan;28(1):16-21. doi: 10.1136/ejhpharm-2019-001889. Epub 2019 Jun 13. Eur J Hosp Pharm. 2021. PMID: 33355279 Free PMC article.
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.
Fernández-Bargiela N, Rotea-Salvo S, Margusino-Framiñán L, Balboa-Barreiro V, Martín-Herranz I, Castro-Iglesias Á, Mena-De-Cea Á, López-Calvo S, Vázquez-Rodríguez P, Míguez-Rey E, Cid-Silva P. Fernández-Bargiela N, et al. Among authors: castro iglesias a. Eur J Hosp Pharm. 2022 Jul;29(4):207-211. doi: 10.1136/ejhpharm-2020-002374. Epub 2020 Oct 13. Eur J Hosp Pharm. 2022. PMID: 33051194 Free PMC article.
56 results